RESEARCH TRIANGLE PARK, NC and GENEVA, SWITZERLAND--(Marketwire - November 05, 2007) - SCYNEXIS and Drugs for Neglected Diseases initiative (DNDi) have agreed to collaborate on vital drug discovery research and development of affordable and effective therapies for human African trypanosomiasis (also known as sleeping sickness), one of the most devastating diseases in sub-Saharan Africa.
